Finance

Lists
NPPNY:OTCMKTS
Nippon Shinyak Unsponsored ADR Representing Ord Shs
$5.32
0.00%
(0.00) 1D
Nov 12, 1:29:23 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NPPNY...
Mkt. cap
237.66B
Avg. vol.
95.00
Volume
4.00
52-wk high
$15.21
52-wk low
$5.05
Beta
-0.05
Shares outstanding
281.00M
No. of employees
2K
Mkt. cap
237.66B
Avg. vol.
95.00
Volume
4.00
52-wk high
$15.21
52-wk low
$5.05
Beta
-0.05
Shares outstanding
281.00M
No. of employees
2K
News stories
From web sources and news partners
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods. Nippon Shinyaku has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyak Unsponsored ADR Representing Ord Shs
CEO-
Employees2.31K
FoundedOct 1, 1919
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
47.49B
43.64B
49.07B
48.76B
Cost of goods sold
16.68B
15.45B
17.73B
16.78B
Cost of revenue
16.68B
15.45B
17.73B
16.78B
Research and development expenses
8.40B
13.68B
9.20B
11.48B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.35B
10.89B
11.08B
11.69B
Operating expense
18.06B
27.55B
19.03B
25.02B
Total operating expenses
34.73B
43.00B
36.75B
41.80B
Operating income
12.75B
639.00M
12.31B
6.96B
Other non operating income
-2.00M
323.00M
-1.00M
-2.00M
EBT including unusual items
13.20B
3.24B
12.96B
7.04B
EBT excluding unusual items
13.20B
3.35B
12.96B
7.04B
Income tax expense
3.11B
-642.00M
2.85B
1.68B
Effective tax rate
23.57%
-19.83%
22.00%
23.85%
Other operating expenses
-1.68B
2.01B
-1.24B
1.85B
Net income
10.08B
3.88B
10.11B
5.36B
Net profit margin
21.23%
8.88%
20.60%
11.00%
Earnings per share
-
-
-
-
Interest and investment income
464.00M
119.00M
689.00M
148.00M
Interest expense
-19.00M
-
-41.00M
-62.00M
Net interest expenses
445.00M
119.00M
648.00M
86.00M
Depreciation and amortization charges
-
974.00M
-
-
EBITDA
14.41B
2.38B
14.09B
8.81B
Gain or loss from assets sale
56.00M
56.00M
-473.00M
181.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps